isradipine has been researched along with Focal Segmental Glomerulosclerosis in 1 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Futrakul, P | 1 |
| Futrakul, N | 1 |
| Sitprija, V | 1 |
| Sensirivatana, R | 1 |
| Watana, D | 1 |
| Kingwatanakul, P | 1 |
1 other study available for isradipine and Focal Segmental Glomerulosclerosis
| Article | Year |
|---|---|
Improved renal perfusion prevents disease progression in focal segmental glomerulosclerosis.
Topics: Cilazapril; Dipyridamole; Disease Progression; Glomerulosclerosis, Focal Segmental; Heparin; Humans; | 1995 |